Incidence of malignancies in patients with juvenile idiopathic arthritis: A retrospective single-center cohort study in Germany

References

• Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–2.
   PubMed Web of Science ®Google Scholar
• Ravelli A and Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369(9563):767–78.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, and Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–44.
   PubMed Web of Science ®Google Scholar
• Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheumat. 2006;54(3):692–701.
   PubMed Web of Science ®Google Scholar
• Smitten AL, Simon TA, Hochberg MC, and Suissa S. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther. 2008;10(2):R45.
   PubMed Web of Science ®Google Scholar
• Mercer LK, Green AC, Galloway JB, Davies R, Lunt M, Dixon WG, et al. The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British society for rheumatology biologics register. Ann Rheum Dis. 2012;71(6):869–74.
   PubMed Web of Science ®Google Scholar
• Ramiro S, Gaujoux-Viala C, Nam JL, Smolen JS, Buch M, Gossec L, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis. 2014;73(3):529–35.
   PubMed Web of Science ®Google Scholar
• Ruperto N and Martini A. Juvenile idiopathic arthritis and malignancy. Rheumatology (Oxford). 2014;53(6):968–74.
   PubMed Web of Science ®Google Scholar
• Mannion ML and Beukelman T. Risk of malignancy associated with biologic agents in pediatric rheumatic disease. Curr Opin Rheumatol. 2014;26(5):538–42.
   PubMed Web of Science ®Google Scholar
• Nordstrom BL, Mines D, Gu Y, Mercaldi C, Aquino P, and Harrison MJ. Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents. Arthritis Care Res (Hoboken). 2012;64(9):1357–64.
   PubMed Web of Science ®Google Scholar
• Simard JF, Neovius M, Hagelberg S, and Askling J. Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study. Arthritis Rheum. 2010;62(12):3776–82.
   PubMed Web of Science ®Google Scholar
• Beukelman T, Haynes K, Curtis JR, Xie F, Chen L, Bemrich-Stolz CJ, et al. Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 2012;64(4):1263–71.
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Rosenberg AM, Oen KG, Duffy CM, Ramsey-Goldman R, Labrecque J, et al. Malignancies in juvenile idiopathic arthritis: a preliminary report. J Rheumatol. 2011;38(4):760–3.
   PubMed Web of Science ®Google Scholar
• Baecklund E, Ekbom A, Sparen P, Feltelius N, and Klareskog L. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ. 1998;317(7152):180–1.
   PubMed Web of Science ®Google Scholar
• Burmester GR, Panaccione R, Gordon KB, McIlraith MJ, and Lacerda AP. Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease. Ann Rheum Dis. 2013;72(4):517–24.
   PubMed Web of Science ®Google Scholar
• Hashkes PJ, Uziel Y, and Laxer RM. The safety profile of biologic therapies for juvenile idiopathic arthritis. Nat Rev Rheumatol. 2010;6(10):561–71.
   PubMed Web of Science ®Google Scholar
• Minden K, Klotsche J, Niewerth M, Horneff G, and Zink A. [Biologics register JuMBO. Long-term safety of biologic therapy of juvenile idiopathic arthritis]. Z Rheumatol. 2013;72(4):339–46.
   PubMed Web of Science ®Google Scholar
• Klostermann S, Haas JP, Schlichtiger J, Molz J, Bisdorff B, Michels H, et al. Health-related quality of life in German patients with Juvenile Idiopathic Arthritis in comparison to German general population. [in submission]. 2015;n/a.
   Google Scholar
• The European Community Respiratory Health Survey II: Main questionnaire. Available from: http://www.ecrhs.org/Quests/ECRHSIImainquestionnaire.pdf
   Google Scholar
• Behrens T, Taeger D, Maziak W, Duhme H, Rzehak P, Weiland SK, et al. Self-reported traffic density and atopic disease in children. Results of the ISAAC phase III survey in Muenster, Germany. Pediatr Allergy Immunol. 2004;15(4):331–9.
   PubMed Web of Science ®Google Scholar
• Radon K, Wengenroth L, Haas JP, and Michels H. Retrospektive Pilotstudie zu TNF-alpha-Inhibitoren und malignen Erkrankungen bei Patienten mit juveniler idiopathischer Arthritis. DGRh Congress; CCH Congress Center Hamburg, Germany, 2010.
   Google Scholar
• Krumrey-Langkammerer M and Hafner R. Evaluation of the ILAR criteria for juvenile idiopathic arthritis. J Rheumatol. 2001;28(11):2544–7.
   PubMed Web of Science ®Google Scholar
• Duffy CM, Colbert RA, Laxer RM, Schanberg LE, and Bowyer SL. Nomenclature and classification in chronic childhood arthritis: Time for a change? Arthritis & Rheumat. 2005;52(2):382–5.
   PubMed Web of Science ®Google Scholar
• Krebsregister, Saarland. Gesundheitsberichterstattung (GBE) Krebsregister Saarland. Available from: http://www.krebsregister.saarland.de/
   Google Scholar
• Preston DL, L J, Pierce DA, McConney ME. Epicure, release 2.10. Seattle, WA: HiroSoft; 1998.
   Google Scholar
• Mariette X, Matucci-Cerinic M, Pavelka K, Taylor P, van Vollenhoven R, Heatley R, et al. Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis. Ann Rheum Dis. 2011;70(11):1895–904.
   PubMed Web of Science ®Google Scholar
• Robert Koch Institut. Krebs in Deutschland 2009/2010. Berlin: Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V.; 2013.
   Google Scholar
• Barth S, Schlichtiger J, Bisdorff B, Hugle B, Michels H, Radon K, et al. Association between drug intake and incidence of malignancies in patients with Juvenile Idiopathic Arthritis: a nested case-control study. Pediatr Rheumatol Online J. 2016;14(1):6.
   PubMed Web of Science ®Google Scholar